13292-46-1 (利福平,Rifampicin)

利福平;甲哌力复霉素;利福霉素-S;3-(((4-甲基-1-哌嗪基)亚氨基)甲基)-利福霉素;异丁哌力复霉素;异丁基哌嗪利福霉素;利福霉素SV;力复霉素SV;利福霉素SV钠;利福;利福定;利福霉素;利福平 EP标准品;利福平 USP标准品;利福平 标准品;利福平杂质对照品;利福平(低温保存);利福平-13C-D3;3-[[(4-甲基-1-哌嗪基)亚氨基]甲基]-利福霉素;甲哌利福霉素;抗厌氧菌药;树脂天青;3-(4-甲基-1-哌嗪基亚胺甲基)利福霉素SV;利米定;雷發平;力复平;立福平;力复霉素;利福平粉;利福平晶体;Rifampicin 利福平;利福平溶液;

rifampicin;3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV;Rifamycin SV Sodium;Rifandin;3-(4-METHYLPIPERAZINYLIMINOMETHYL)RIFAMYCIN SV;RIFAMPICIN(RG);3-(4-Methylpiperazinyliminomethyl)rifamycin SV,Rifampin,Rifamycin AMP;AMP;arficin;FaMcin;Resazurin;rifagen;Rifamycin AMP;rifinah;3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin;ARHF;RHOF;l-5103;Rimactane;Rifampicinum;Tubocin;Rifoldine;Rimactizid;Archidyn;Rimazid;Rifampicin SV;R/AMP;Rifampicina;Rifamor;Benemicin;Sinerdol;Rifadine;Rifaldazin;Rimactazid;Fenampicin;Doloresum;Rifcin;Arzide;Rifam;Dione 21-acetate;Rifampicine [French];Rifampicinum [INN-Latin];Ba 41166/E;Rifampicina [INN-Spanish];3-(((4-Methyl-1-piper;SR-05000002118-3;5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;HMS3713J11;2,7-(EPOXYPENTADECA(1,11,13)TRIENIMINO)NAPHTHO(2,1-B)FURAN-1,11(2-H)-DIONE, 5,6,9,17,19,21-HEXAHYDROXY-23-METHOXY-2,4,12,1///;RIFAMPICIN [INN];Rimactane (TN);rifamcin;Reserpine & Rifampicin;HMS1569J11;Rifamsolin;BDBM50370232;GR-306;Rifampicin, European Pharmacopoeia (EP) Reference Standard;RIFAMPICIN (IARC);RIFAMPICIN (EP IMPURITY);RIFAMPICIN [JAN];RIFAMYCIN AMP [MI];C06688;D00211;Rifampicine;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate;RIFAMPIN COMPONENT OF RIFATER;Rifampicin, >=97% (HPLC), powder;Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline;NSC-113926;CHEMBL374478;2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate;NCGC00022678-03;Rifampin, United States Pharmacopeia (USP) Reference Standard;RIFAMPIN COMPONENT OF RIFAMATE;AZT + Rifampin;BA-41166/E;Rifampicin & EEP;8CI);3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN;8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin;RIFAMPIN (USP MONOGRAPH);BPBio1_000561;Prestwick3_000525;CCG-208267;BA 411661E;yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-;Rifampin (Rifampicin);3-((4-METHYL-1-PIPERAZINYL)IMINOMETHYL)RIFAMYCIN SV;RIFAMPIN [MI];Rifampin [USAN];Spectrum5_002018;3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV;3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate;2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate;5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate;MFCD00151389;Ba 41166;RIFATER COMPONENT RIFAMPIN;Rifampin (USP);HMS2096J11;Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-;NSC113926;Rifampicin - CAS 13292-46-1;UNII-VJT6J7R4TR;8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv;3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV;Prestwick_833;AKOS015951372;RIFAMPICIN (EP MONOGRAPH);Rifampin (USAN:USP);Rifampicinum (INN-Latin);SCHEMBL23490;8-(4-Methylpiperazinyliminomethyl) rifamycin SV;RIFAMPIN [HSDB];CHEBI:28077;BSPBio_000509;NIH-10782;RIFAMPICIN [WHO-IP];Rifampicin, powder, gamma-irradiated;Rifadin Iv;RIFAMPIN [ORANGE BOOK];Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-;R-Cin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac;Rifadin (TN);(2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate;AB00383022_07;8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv;2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (;BA-41166E;3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV;DTXSID6021244;Rifampin [USAN:USP];RIFAMPICIN [EP IMPURITY];RIFAMPIN [VANDF];3-(4-Methylpiperazinyliminomethyl)-rifamycin SV;RIFAMPICIN (MART.);Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate;NCGC00022678-04;SR-05000002118;RIFAMPICIN [MART.];13292-46-1;L-5103 Lepetit;Rifadin IV NOVAPLUS;NCGC00022678-05;(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11- methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino] methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1 (28),2,4,9,19,21,25(29),26-octaen-13-yl acetate;NSC 113926;DTXCID301244;WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1;5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate;(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate;RIFAMPICIN [IARC];Rifampicin, >=97.0% (HPLC);Rifampicin, VETRANAL(TM), analytical standard;RIFAMPIN [USP MONOGRAPH];Prestwick2_000525;HMS2089F12;RIFAMPICIN [EP MONOGRAPH];RIFAMPICIN [WHO-DD];RFP;Rifapiam;2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth;RIFAMATE COMPONENT RIFAMPIN;Rifampicina (INN-Spanish);Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material;CCRIS 551;J04AB02;Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-;RIFAMPICINUM [WHO-IP LATIN];5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate;L-5103-LEPETIT;8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV;DRG-0109;Rifampicin [INN:BAN:JAN];HSDB 3181;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acet;Rifampicin (JP17/INN);(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-((4-methylpiperazin-1-yl)imino)methyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.1(4,7).0(5,28))triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate;DB01045;VJT6J7R4TR;NCGC00022678-06;Rifampicin & Propolis;Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-;Piperine & Rifampicin;EINECS 236-312-0;Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline;[pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate;[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate;3-((4-methylpiperazin-1-yl)iminomethyl)rifamycin;Rifampicin (Rifampin);Rifampicin D4;Rifampicin (JP18/INN);1ST10166;

MFCD00151389

JQXXHWHPUNPDRT-WLSIYKJHSA-N

1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1

O(C(C)=O)[C@@H]1[C@H](C)[C@H](C=CO[C@]2(C)C(C3C4C(=C(/C=N/N5CCN(C)CC5)C(=C(C=4C(=C(C)C=3O2)O)O)NC(C(C)=CC=C[C@H](C)[C@@H]([C@@H](C)[C@H]([C@H]1C)O)O)=O)O)=O)OC |c:44,t:8,46|

236-312-0

2941903000

5723476

5723476